Wired to learn and remember 

Wired to learn and remember 

New research unveils how spinal cord nerve cells can learn and remember—completely independent of the brain 

April 12, 2024
AI predicts the taste and quality of beer

AI predicts the taste and quality of beer

Revolutionizing the beverage industry and making better beer

March 26, 2024

Flemish researchers launch OPENPichia, an industrial open access yeast system for the production of proteins

Flemish researchers launch OPENPichia, an industrial open access yeast system for the production of proteins

The system has applications in the production of medicines, and edible and industrial proteins, offering a cheaper and qualitative alternative to existing commercial variants

March 5, 2024

Newly discovered protein blocks sleeping sickness 

Newly discovered protein blocks sleeping sickness 

New research by the lab of Prof. Jo Van Ginderachter (VIB Center for Inflammation Research and VUB), in collaboration with Prof. Carl De Trez (VUB) and others, identifies a protein that could pave the way toward drugs against sleeping sickness.

February 28, 2024

Erosion blockade breakthrough: clinical trial signals hope for hand osteoarthritis

Erosion blockade breakthrough: clinical trial signals hope for hand osteoarthritis

Researchers at the Ghent University Hospital, Ghent University, and VIB-UGent Center for Inflammation Research, show that antibody therapy can be effective against erosive hand osteoarthritis. Using the antibody denosumab leads to bone remodeling and the prevention of erosive joint damage. This is the first evidence that erosive progression can be halted in this disease. The results appear in Nature Medicine.

February 15, 2024

Contact us

Joran Lauwers .jpg

Joran Lauwers

Science & Business Communications Expert, VIB

About VIB

VIB’s core mission is to generate disruptive insights in the molecular underpinning of life and to translate these actively into impactful innovations for patients and society. VIB is an independent research institute where some 1,800 top scientists from Belgium and abroad conduct pioneering basic research. As such, they are pushing the boundaries of what we know about molecular mechanisms and how they rule living organisms such as human beings, animals, plants, and microorganisms. Based on a close partnership with five Flemish universities – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel, and Hasselt University – and supported by a solid funding program, VIB unites the expertise of all its collaborators and research groups in a single institute. VIB’s technology transfer activities translate research results into concrete benefits for society such as new diagnostics and therapies and agricultural innovations. These applications are often developed by young start-ups from VIB or through collaborations with other companies. This also leads to additional employment and bridges the gap between scientific research and entrepreneurship. VIB also engages actively in the public debate on biotechnology by developing and disseminating a wide range of science-based information. 

More info can be found on www.vib.be.

Contact